These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: L-threo-3,4-dihydroxyphenylserine treatment for gait apraxia in parkinsonian patients.
    Author: Yoshida M, Noguchi S, Kuramoto S.
    Journal: Kurume Med J; 1989; 36(2):67-74. PubMed ID: 2511378.
    Abstract:
    L-threo-3,4-dihydroxyphenylserine (L-DOPS) was administered to six parkinsonian patients for the treatment of gait related akinesia which was refractile to L-DOPA treatment. One responded with marked improvement and one with only mild improvement. Although number of patients who respond markedly to this noradrenaline precursor, L-DOPS, is limited, L-DOPS was felt to be the most effective treatment modality for L-DOPA refractile gait related akinesia and L-DOPA related orthostatic hypotension.
    [Abstract] [Full Text] [Related] [New Search]